ReviewAnnals of the rheumatic diseases2024
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story.
Michael Bonelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
86 papers cite itlatest 60 shown
this paperpooled ittrialcites it